chr2-53714483-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_016115.5(ASB3):āc.881A>Gā(p.Asp294Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000118 in 1,614,118 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_016115.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ASB3 | NM_016115.5 | c.881A>G | p.Asp294Gly | missense_variant | 7/10 | ENST00000263634.8 | NP_057199.1 | |
GPR75-ASB3 | NM_001164165.2 | c.995A>G | p.Asp332Gly | missense_variant | 7/10 | NP_001157637.1 | ||
ASB3 | NM_001201965.2 | c.662A>G | p.Asp221Gly | missense_variant | 6/9 | NP_001188894.1 | ||
ASB3 | NM_145863.3 | c.662A>G | p.Asp221Gly | missense_variant | 6/9 | NP_665862.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152246Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000562 AC: 14AN: 249004Hom.: 0 AF XY: 0.0000445 AC XY: 6AN XY: 134788
GnomAD4 exome AF: 0.000126 AC: 184AN: 1461872Hom.: 1 Cov.: 31 AF XY: 0.000113 AC XY: 82AN XY: 727240
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152246Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74376
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 29, 2023 | The c.881A>G (p.D294G) alteration is located in exon 7 (coding exon 6) of the ASB3 gene. This alteration results from a A to G substitution at nucleotide position 881, causing the aspartic acid (D) at amino acid position 294 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at